太叔千愁
Lv41
788 积分
2022-06-30 加入
-
An analysis of the attrition of drug candidates from four major pharmaceutical companies
5天前
已完结
-
Absorption, Distribution, Metabolism, and Excretion of Therapeutic Proteins: Current Industry Practices and Future Perspectives
8天前
已完结
-
Metabolism and Excretion of Therapeutic Peptides: Current Industry Practices, Perspectives, and Recommendations
8天前
已完结
-
POS1200 MRT-6160, A VAV1-DIRECTED MOLECULAR GLUE DEGRADER, REDUCES JOINT INFLAMMATION, CYTOKINE PRODUCTION, AND AUTOANTIBODY LEVELS IN A COLLAGEN-INDUCED ARTHRITIS DISEASE MODEL
21天前
已关闭
-
P164 MRT-6160, a VAV1-directed molecular glue degrader, inhibits disease progression and inflammation in a T-cell transfer model of Colitis
21天前
已完结
-
An update on the importance of plasma protein binding in drug discovery and development
1个月前
已完结
-
Preclinical Pharmacokinetics and Interspecies Scaling of a Novel Vitronectin Receptor Antagonist
3个月前
已完结
-
Species difference in brain penetration of P-gp and BCRP substrates among monkey, dog and mouse
3个月前
已完结
-
Effects of donepezil on cortical metabolic response to activation during 18FDG-PET in Alzheimer’s disease: a double-blind cross-over trial
4个月前
已完结
-
PET imaging shows loss of striatal PDE10A in patients with Huntington disease
4个月前
已关闭